BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17687887)

  • 1. The control of impurities in chlortalidone using a reversed-phase stationary phase.
    Douville V; Keller E; Lambertz K; Lodi A; Miller JH
    Pharmeur Sci Notes; 2005 Aug; 2005(1):5-10. PubMed ID: 17687887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The control of impurities in amitriptyline hydrochloride using a reversed-phase hybrid stationary phase.
    Dixon SP; Lodi A; Miller JH; Skellern GG
    Pharmeur Sci Notes; 2005 Aug; 2005(1):15-20. PubMed ID: 17687889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A liquid chromatographic method using a reversed-phase hybrid stationary phase to control potential impurities of imipramine hydrochloride.
    Dixon SP; La Torre F; Lodi A; Miller JH; Skellern GG
    Pharmeur Sci Notes; 2006 Dec; 2006(2):35-9. PubMed ID: 17691212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPLC method for the simultaneous determination of atenolol and chlorthalidone in human breast milk.
    El-Gindy A; Sallam S; Abdel-Salam RA
    J Sep Sci; 2008 Mar; 31(4):677-82. PubMed ID: 18266291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPLC and chemometric-assisted spectrophotometric methods for simultaneous determination of atenolol, amiloride hydrochloride and chlorthalidone.
    El-Gindy A; Emara S; Mostafa A
    Farmaco; 2005 Mar; 60(3):269-78. PubMed ID: 15784248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability indicating UPLC method for simultaneous determination of atorvastatin, fenofibrate and their degradation products in tablets.
    Kadav AA; Vora DN
    J Pharm Biomed Anal; 2008 Sep; 48(1):120-6. PubMed ID: 18583084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversed phase ion-pair high performance liquid chromatographic gradient separation of related impurities in 2,4-disulfonic acid benzaldehyde di-sodium salt.
    Lu B; Jonsson P; Blomberg S
    J Chromatogr A; 2006 Jun; 1119(1-2):270-6. PubMed ID: 16378614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a validated RP-LC/ESI-MS-MS method for separation, identification and determination of related substances of tamsulosin in bulk drugs and formulations.
    Nageswara Rao R; Kumar Talluri MV; Narasa Raju A; Shinde DD; Ramanjaneyulu GS
    J Pharm Biomed Anal; 2008 Jan; 46(1):94-103. PubMed ID: 17951020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A validated reversed phase HPLC method for the determination of process-related impurities in almotriptan malate API.
    Kumar AP; Ganesh VR; Rao DV; Anil C; Rao BV; Hariharakrishnan VS; Suneetha A; Sundar BS
    J Pharm Biomed Anal; 2008 Mar; 46(4):792-8. PubMed ID: 18191357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An efficient separation and method development for the quantifying of two basic impurities of Nicergoline by reversed-phase high performance liquid chromatography using ion-pairing counter ions.
    Yalçin G; Yüktaş N
    J Pharm Biomed Anal; 2006 Oct; 42(4):434-40. PubMed ID: 16766155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous separation and determination of coenzyme Q(10) and its process related impurities by NARP-HPLC and atmospheric pressure chemical ionization-mass spectrometry (APCI-MS).
    Nageswara Rao R; Kumar Talluri MV; Shinde DD
    J Pharm Biomed Anal; 2008 Jun; 47(2):230-7. PubMed ID: 18243624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct high-performance liquid chromatography enantioseparation of terazosin on an immobilised polysaccharide-based chiral stationary phase under polar organic and reversed-phase conditions.
    Ferretti R; Gallinella B; La Torre F; Zanitti L; Turchetto L; Mosca A; Cirilli R
    J Chromatogr A; 2009 Jul; 1216(28):5385-90. PubMed ID: 19493532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal phase and reverse phase HPLC-UV-MS analysis of process impurities for rapamycin analog ABT-578: application to active pharmaceutical ingredient process development.
    Chen Y; Brill GM; Benz NJ; Leanna MR; Dhaon MK; Rasmussen M; Zhou CC; Bruzek JA; Bellettini JR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):106-17. PubMed ID: 17826364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and proportion of the enantiomers of the antihypertensive drug chlortalidone in its Form II by high quality single-crystal X-ray diffraction data.
    Santos LM; Santos OMM; Mendes PF; Rosa IML; Silva CCD; Bonfilio R; de Araujo MB; Boralli VB; Doriguetto AC; Martins FT
    J Pharm Biomed Anal; 2016 Jan; 118():101-104. PubMed ID: 26528899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing and optimizing a validated isocratic reversed-phase high-performance liquid chromatography separation of nimodipine and impurities in tablets using experimental design methodology.
    Barmpalexis P; Kanaze FI; Georgarakis E
    J Pharm Biomed Anal; 2009 Jul; 49(5):1192-202. PubMed ID: 19369025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the utility of ion mobility separation in combination with high-pressure liquid chromatography/mass spectrometry to facilitate detection of trace impurities in formulated drug products.
    Eckers C; Laures AM; Giles K; Major H; Pringle S
    Rapid Commun Mass Spectrom; 2007; 21(7):1255-63. PubMed ID: 17340559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a quality-by-design approach to justify removal of the HPLC weight % assay from routine API stability testing protocols.
    Skrdla PJ; Wang T; Antonucci V; Dowling T; Ge Z; Ellison D; Curran J; Mohan G; Wyvratt J
    J Pharm Biomed Anal; 2009 Dec; 50(5):794-6. PubMed ID: 19596534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of potential impurities of valsartan, AT1 receptor antagonist.
    Sampath A; Reddy AR; Yakambaram B; Thirupathi A; Prabhakar M; Reddy PP; Reddy VP
    J Pharm Biomed Anal; 2009 Oct; 50(3):405-12. PubMed ID: 19560892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thin layer densitometry in the quantitative assay of drugs. Note V--Assay of reserpine and chlorthalidone in the presence of the potential impurities of their solid pharmaceutical forms.
    Corti P; Corbini G; Dreassi E; Murratzu C; Celesti L
    Pharm Acta Helv; 1990; 65(8):222-7. PubMed ID: 2236179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LC determination of glimepiride and its related impurities.
    Khan MA; Sinha S; Vartak S; Bhartiya A; Kumar S
    J Pharm Biomed Anal; 2005 Oct; 39(5):928-43. PubMed ID: 16040224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.